1. Home
  2. KRNT vs AVXL Comparison

KRNT vs AVXL Comparison

Compare KRNT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • AVXL
  • Stock Information
  • Founded
  • KRNT 2002
  • AVXL 2004
  • Country
  • KRNT Israel
  • AVXL United States
  • Employees
  • KRNT N/A
  • AVXL N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KRNT Industrials
  • AVXL Health Care
  • Exchange
  • KRNT Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • KRNT 893.9M
  • AVXL 794.0M
  • IPO Year
  • KRNT 2015
  • AVXL N/A
  • Fundamental
  • Price
  • KRNT $21.48
  • AVXL $11.09
  • Analyst Decision
  • KRNT Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • KRNT 5
  • AVXL 2
  • Target Price
  • KRNT $33.20
  • AVXL $44.00
  • AVG Volume (30 Days)
  • KRNT 177.3K
  • AVXL 1.1M
  • Earning Date
  • KRNT 08-06-2025
  • AVXL 08-05-2025
  • Dividend Yield
  • KRNT N/A
  • AVXL N/A
  • EPS Growth
  • KRNT N/A
  • AVXL N/A
  • EPS
  • KRNT N/A
  • AVXL N/A
  • Revenue
  • KRNT $206,506,000.00
  • AVXL N/A
  • Revenue This Year
  • KRNT $10.86
  • AVXL N/A
  • Revenue Next Year
  • KRNT $12.68
  • AVXL N/A
  • P/E Ratio
  • KRNT N/A
  • AVXL N/A
  • Revenue Growth
  • KRNT N/A
  • AVXL N/A
  • 52 Week Low
  • KRNT $13.59
  • AVXL $4.93
  • 52 Week High
  • KRNT $34.29
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 59.51
  • AVXL 63.85
  • Support Level
  • KRNT $19.72
  • AVXL $9.91
  • Resistance Level
  • KRNT $21.98
  • AVXL $11.33
  • Average True Range (ATR)
  • KRNT 0.68
  • AVXL 0.60
  • MACD
  • KRNT 0.26
  • AVXL 0.04
  • Stochastic Oscillator
  • KRNT 84.44
  • AVXL 83.70

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: